KIA
ABBV icon

Koenig Investment Advisory’s AbbVie ABBV Stock Holding History

Koenig Investment Advisory’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.17M Sell
12,586
-242
-2% -$52.1K 2.46% 11
2026
Q1 		$2.79M Sell
12,828
-208
-2% -$46.1K 2.37% 10
2025
Q4 		$2.93M Buy
+13,036
New +$2.97M 2.37% 11

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Koenig Investment Advisory's ABBV Position: Q2 2026 in Review

Koenig Investment Advisory reduced its AbbVie (ABBV) stake by 1.9% in Q2 2026, selling an estimated $52.1K and leaving 12,586 shares worth $3.17M. The position accounts for 2.46% of the portfolio, ranked #11.

Koenig Investment Advisory first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. 4,188 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Koenig Investment Advisory held 12,586 shares of AbbVie worth $3.17M as of Q2 2026.
  • Koenig Investment Advisory sold 242 AbbVie shares in Q2 2026, an estimated $52.1K.
  • AbbVie made up 2.46% of Koenig Investment Advisory's portfolio in Q2 2026, its #11 holding.
  • Koenig Investment Advisory first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • 4,188 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Koenig Investment Advisory's 13F filing for Q2 2026, filed 16 Jul 2026.